Commercial Development of a Novel Microfluidic Platform for Real-Time Biopharmaceutical Analysis
IC Name
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
-
Activity
R44
-
Administering IC
TR
-
Application Type
4
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
1996782
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
350
-
Ed Inst. Type
-
Funding ICs
NCATS:1996782\
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZRG1
-
Study Section Name
Special Emphasis Panel